Symbols

RGEN

Repligen·NASDAQ

--(--)

RGEN fundamentals

RGEN Q4 2025 Earnings

Repligen (RGEN) released its earnings on Feb 24, 2026: revenue was 197.91M (YoY +18.12%), beat estimates; EPS was 0.49 (YoY +11.36%), beat estimates.

Revenue / YoY

197.91M

+18.12%

EPS / YoY

0.49

+11.36%

Report date

Feb 24, 2026

RGEN Earnings Call Summary for Q4,2025

Revenue Growth: 14% organic in 2025, with 2026 guidance of 10-14% driven by Analytics upgrades and China recovery.
Margin Expansion: 150bps target in 2026, supported by volume leverage and pricing, offset by minor tariff headwinds.
Strategic Wins: SoloVPE PLUS upgrades, China market expansion, and service cross-selling initiatives.
Risks: Tariff uncertainty, MFN-related CapEx delays, and FX volatility.

Earnings

EPS

Revenue

Revenue & Expenses

RGEN has released its 2025 Q4 earnings report, with revenue of 197.91M, reflecting a YoY change of 18.12%, and net profit of 13.29M, showing a YoY change of 139.23%. The Sankey diagram below clearly presents RGEN's revenue sources and cost distribution.

Key Indicators

Repligen (RGEN) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Repligen (RGEN)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Repligen (RGEN)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Repligen (RGEN)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown